Literature DB >> 9032087

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

C T Montague1, J B Prins, L Sanders, J E Digby, S O'Rahilly.   

Abstract

Obese subjects with excess intra-abdominal fat deposition suffer greater adverse metabolic consequences than do similarly overweight subjects with a predominantly subcutaneous distribution of adiposity. Little is known about the factors regulating the regional distribution of body fat. Leptin is a recently characterized protein secreted by adipocytes that appears to provide a long-term hormonal feedback signal regulating fat mass. No systematic evaluation of site-related differences in human adipocyte leptin expression has been reported to date. Levels of leptin mRNA were examined by quantitative reverse transcription-polymerase chain reaction in adipocytes isolated from omental and subcutaneous adipose depots of nonobese and mildly obese individuals undergoing elective surgery. In all individuals studied (n = 24), leptin mRNA levels were higher in subcutaneous than in omental adipocytes (P < 0.0001). In contrast, there were no consistent site-specific differences in the expression of glycerol-3-phosphate dehydrogenase mRNA. The subcutaneous-to-omental ratio of leptin mRNA expression was markedly higher in women (5.5 +/- 1.1-fold) than in men (1.9 +/- 0.2-fold) (P < 0.02). A significant relationship between BMI and leptin mRNA expression was demonstrable in the subcutaneous adipocytes of women (P < 0.006). Thus, leptin mRNA appears to be expressed predominantly by subcutaneous adipocytes, particularly in women. These findings suggest a possible role for leptin in the control of adipose tissue distribution and mass.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032087     DOI: 10.2337/diab.46.3.342

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  101 in total

Review 1.  Demystified ... the polymerase chain reaction.

Authors:  K R Baumforth; P N Nelson; J E Digby; J D O'Neil; P G Murray
Journal:  Mol Pathol       Date:  1999-02

Review 2.  Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?

Authors:  P G Kopelman
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 3.  Regulation of leptin production.

Authors:  R V Considine
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

Review 4.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

5.  Effects of a 3-week integrated body weight reduction program on leptin levels and body composition in severe obese subjects.

Authors:  A Sartorio; F Agosti; M Resnik; C L Lafortuna
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

6.  Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification.

Authors:  Jonathan Golledge; Rumal Jayalath; Lisa Oliver; Adam Parr; Leon Schurgers; Paula Clancy
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

7.  The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity.

Authors:  M A Vasilenko; E V Kirienkova; D A Skuratovskaia; P A Zatolokin; N I Mironyuk; L S Litvinova
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

8.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Beyond thermoregulation: metabolic function of cetacean blubber in migrating bowhead and beluga whales.

Authors:  H C Ball; R L Londraville; J W Prokop; John C George; R S Suydam; C Vinyard; J G M Thewissen; R J Duff
Journal:  J Comp Physiol B       Date:  2016-08-29       Impact factor: 2.200

10.  Presence of bovine leptin in edible commercial milk and infant formula.

Authors:  M Lage; R Baldelli; J P Camiña; J Rodriguez-Garci; A Peñalva; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.